By making a commitment and pledging a monthly donation of your choice, you too can make a significant difference to our world-leading research and clinical trials, and most importantly, for people living with eye disease.
This year CERA’s Annual Review highlights some of the incredible people supporting us on our mission to develop better treatments and faster diagnoses for eye disease.
In this video, learn about CERA’s research into gene therapies that could halt or even reverse vision loss in patients with conditions such as inherited retinal diseases and glaucoma.
The discovery of molecular signatures of age-related macular degeneration has the potential to improve both the diagnosis and treatment of this progressive eye disease.
A new start-up company aiming to develop a gene therapy to ‘switch on sight’ by restoring the retina’s light-sensing cells has won vital funding to accelerate its research.
Research aimed at improving the screening process for diabetic eye disease and better understanding communication between the retina and brain has received new support.
